The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| AGEX THEREPEUTICS INC | COM | 00848H108 | 165,407 | 185,185 | SH | SOLE | 185,185 | 0 | 0 | |||
| CIMPRESS PLC | SHS EURO | G2143T103 | 232,358,144 | 3,906,492 | SH | SOLE | 3,906,492 | 0 | 0 | |||
| CREDIT ACCEP CORP MICH | COM | 225310101 | 792,377,911 | 1,560,014 | SH | SOLE | 1,560,014 | 0 | 0 | |||
| GLOBAL INDUSTRIAL COMPANY | COM | 37892E102 | 29,747,835 | 1,071,222 | SH | SOLE | 1,071,222 | 0 | 0 | |||
| GRINDR INC | COM | 39854F101 | 12,611,740 | 2,280,604 | SH | SOLE | 2,280,604 | 0 | 0 | |||
| HUMACYTE INC | COM | 44486Q103 | 1,625,184 | 568,246 | SH | SOLE | 568,246 | 0 | 0 | |||
| LINEAGE CELL THERAPEUTICS IN | COM | 53566P109 | 2,611,110 | 1,851,851 | SH | SOLE | 1,851,851 | 0 | 0 | |||
| WAYFAIR INC | CL A | 94419L101 | 248,548,767 | 3,823,239 | SH | SOLE | 3,823,239 | 0 | 0 | |||
| WORLD ACCEP CORP DEL | COM | 981419104 | 273,044,705 | 2,037,495 | SH | SOLE | 2,037,495 | 0 | 0 | |||
| YELP INC | CL A | 985817105 | 33,440,619 | 918,446 | SH | SOLE | 918,446 | 0 | 0 | |||